Filing Details

Accession Number:
0001140361-24-038770
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-27 21:00:24
Reporting Period:
2024-08-23
Accepted Time:
2024-08-27 21:00:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368514 Adma Biologics Inc. ADMA Biological Products, (No Disgnostic Substances) (2836) 562590442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1733094 Young Kwon C/O Adma Biologics, Inc.
465 State Route 17
Ramsey NJ 07446
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-23 60,000 $18.26 241,441 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.27. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  2. Includes, as of the transaction date, (i) 12,020 restricted stock units ("RSUs") granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 229,421 shares of common stock owned by the Reporting Person.